Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Collinge

Showing results (11-20 of 28) with videos related to

Pageof 3
Sort By:
ALTEX|August 31, 2022
Application of Immunocompetent Microphysiological Systems in Drug Development: Current Perspective and RecommendationsXiaoting Wang, Anna K Kopec, Mark Collinge, et al.
Journal of Immunotoxicology|March 21, 2012
Developmental immunotoxicity (DIT) testing of pharmaceuticals: current practices, state of the science, knowledge gaps, and recommendationsMark Collinge, Leigh Ann Burns-Naas, Gary J Chellman, et al.
The American Journal of Pathology|February 11, 2012
Macrophage β2 integrin-mediated, HuR-dependent stabilization of angiogenic factor-encoding mRNAs in inflammatory angiogenesisJiange Zhang, Yasha Modi, Timur Yarovinsky, et al.
Plos One|January 6, 2011
T cell LFA-1 engagement induces HuR-dependent cytokine mRNA stabilization through a Vav-1, Rac1/2, p38MAPK and MKK3 signaling cascadeVinod S Ramgolam, Scott D DeGregorio, Gautham K Rao, et al.
The Journal of Biological Chemistry|November 15, 2002
Src kinase mediates phosphatidylinositol 3-kinase/Akt-dependent rapid endothelial nitric-oxide synthase activation by estrogenM Page Haynes, Lei Li, Diviya Sinha, et al.
Plos One|July 27, 2018
T cell LFA-1-induced proinflammatory mRNA stabilization is mediated by the p38 pathway kinase MK2 in a process regulated by hnRNPs C, H1 and KGautham K Rao, Albert Wong, Mark Collinge, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|December 14, 2024
mRNA-LNPs induce immune activation and cytokine release in human whole blood assays across diverse health conditionsHong-My Nguyen, Kristin E Alexander, Mark Collinge, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 9, 2007
Variant estrogen receptor-c-Src molecular interdependence and c-Src structural requirements for endothelial NO synthase activationLei Li, Koji Hisamoto, Kyung Hee Kim, et al.
Journal of Immunotoxicology|February 15, 2023
Current approaches to evaluate the function of cytotoxic T-cells in non-human primatesCris Kamperschroer, Brendon Frank, Caroline Genell, et al.
Journal of Immunotoxicology|March 4, 2020
Cross-company evaluation of the human lymphocyte activation assayMark Collinge, Patricia Schneider, Dingzhou Li, et al.
Pageof 3

Showing results (11-20 of 28) with videos related to

Sort By:
Pageof 3
ALTEX|August 31, 2022
Application of Immunocompetent Microphysiological Systems in Drug Development: Current Perspective and RecommendationsXiaoting Wang, Anna K Kopec, Mark Collinge, et al.
Journal of Immunotoxicology|March 21, 2012
Developmental immunotoxicity (DIT) testing of pharmaceuticals: current practices, state of the science, knowledge gaps, and recommendationsMark Collinge, Leigh Ann Burns-Naas, Gary J Chellman, et al.
The American Journal of Pathology|February 11, 2012
Macrophage β2 integrin-mediated, HuR-dependent stabilization of angiogenic factor-encoding mRNAs in inflammatory angiogenesisJiange Zhang, Yasha Modi, Timur Yarovinsky, et al.
Plos One|January 6, 2011
T cell LFA-1 engagement induces HuR-dependent cytokine mRNA stabilization through a Vav-1, Rac1/2, p38MAPK and MKK3 signaling cascadeVinod S Ramgolam, Scott D DeGregorio, Gautham K Rao, et al.
The Journal of Biological Chemistry|November 15, 2002
Src kinase mediates phosphatidylinositol 3-kinase/Akt-dependent rapid endothelial nitric-oxide synthase activation by estrogenM Page Haynes, Lei Li, Diviya Sinha, et al.
Plos One|July 27, 2018
T cell LFA-1-induced proinflammatory mRNA stabilization is mediated by the p38 pathway kinase MK2 in a process regulated by hnRNPs C, H1 and KGautham K Rao, Albert Wong, Mark Collinge, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|December 14, 2024
mRNA-LNPs induce immune activation and cytokine release in human whole blood assays across diverse health conditionsHong-My Nguyen, Kristin E Alexander, Mark Collinge, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 9, 2007
Variant estrogen receptor-c-Src molecular interdependence and c-Src structural requirements for endothelial NO synthase activationLei Li, Koji Hisamoto, Kyung Hee Kim, et al.
Journal of Immunotoxicology|February 15, 2023
Current approaches to evaluate the function of cytotoxic T-cells in non-human primatesCris Kamperschroer, Brendon Frank, Caroline Genell, et al.
Journal of Immunotoxicology|March 4, 2020
Cross-company evaluation of the human lymphocyte activation assayMark Collinge, Patricia Schneider, Dingzhou Li, et al.
Pageof 3